Damon DeSantis

Board Director

Director

Celsius Holdings, Inc.Integrated Biopharma Inc

Insider activity · 24 months2 buys0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 2 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (2 ops.)

€865k

▼ Sales (0 ops.)

—

Latest filing published 15 Sept 2026 for Celsius Holdings, Inc., €477k. Read the official filing

Filing timeline

BuySale

Damon DeSantis

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Damon DeSantis: trading record in brief

Damon DeSantis (board member) discloses dealings in 2 companies, chiefly Celsius Holdings, Inc. and Integrated Biopharma Inc. In total, 13 filings cover trades dated from 28 October 2021 to 15 September 2026.

No open-market sale appears; the market trades are 2 purchases worth €865k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 6 share grants. Since January 2026: 2 purchases and no sales on the market.

On 15 September 2026 came the latest disclosure, an open-market purchase for €477k in Celsius Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.